Laurus nobilis L. Seed Extract Reveals Collateral Sensitivity in Multidrug-Resistant P-Glycoprotein-Expressing Tumor Cells

REFERENCES

• Gottesman MM and Ling V: The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 580, 998–1009, 2006.
   PubMed Web of Science ®Google Scholar
• Efferth T: The human ATP-binding cassette transporter genes: from the bench to the bedside. Curr Mol Med 1, 45–65, 2001.
   PubMedGoogle Scholar
• Gillet JP, Efferth T, and Remacle J: Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim Biophys Acta 1775, 237–262, 2007.
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Iida H, Tsukagoshi S, and Sakurai Y: Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41, 1967–1972, 1981.
   PubMed Web of Science ®Google Scholar
• Ford JM and Hait WN: Pharmacologic circumvention of multidrug resistance. Cytotechnology 12, 171–212, 1993.
   PubMed Web of Science ®Google Scholar
• Tiwari AK, Sodani K, Dai CL, Ashby CR, Jr., and Chen ZS: Revisiting the ABCs of multidrug resistance in cancer chemotherapy. Curr Pharm Biotechnol 12, 570–594, 2011.
   PubMed Web of Science ®Google Scholar
• Amiri-Kordestani L, Basseville A, Kurdziel K, Fojo AT, and Bates SE: Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies. Drug Resist Updat 15, 50–61, 2012.
   PubMed Web of Science ®Google Scholar
• Eichhorn T and Efferth T: P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs. J Ethnopharmacol 141, 557–570, 2012.
   PubMed Web of Science ®Google Scholar
• Volm M, Efferth T, Gunther A, and Lathan B: Detection of murine S180 cells expressing a multidrug resistance phenotype using different in vitro test systems and a monoclonal antibody. Arzneimittelforschung 37, 862–867, 1987.
   PubMed Web of Science ®Google Scholar
• van Triest B, Pinedo HM, Telleman F, van der Wilt CL, Jansen G, et al.: Cross-resistance to antifolates in multidrug resistant cell lines with P-glycoprotein or multidrug resistance protein expression. Biochem Pharmacol 53, 1855–1866, 1997.
   PubMed Web of Science ®Google Scholar
• Hall MD, Handley MD, and Gottesman MM: Is resistance useless? Multidrug resistance and collateral sensitivity. Trends Pharmacol Sci 30, 546–556, 2009.
   PubMed Web of Science ®Google Scholar
• Saeed MGJ and Efferth T: Collateral sensitivity in drug-resistant tumor cells. In: Tumor Cell Resistance to Apoptosis by Cytotoxic Drugs and Reversal of Resistance by Targeted Sensitizing Cells, Bonavida B (ed.). New York: Springer, 2013, pp. 187–211.
   Google Scholar
• Horwedel C, Tsogoeva SB, Wei S, and Efferth T: Cytotoxicity of artesunic acid homo- and heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells. J Med Chem 53, 4842–4848, 2010.
   PubMed Web of Science ®Google Scholar
• Reiter C, Herrmann A, Capci A, Efferth T, and Tsogoeva SB: New artesunic acid homodimers: potent reversal agents of multidrug resistance in leukemia cells. Bioorg Med Chem 20, 5637–5641, 2012.
   PubMed Web of Science ®Google Scholar
• Kuete V, Tchakam PD, Wiench B, Ngameni B, Wabo HK, et al.: Cytotoxicity and modes of action of four naturally occuring benzophenones: 2,2',5,6'-tetrahydroxybenzophenone, guttiferone E, isogarcinol and isoxanthochymol. Phytomedicine 20, 528–536, 2013.
   PubMed Web of Science ®Google Scholar
• Kuete V, Sandjo LP, Wiench B, and Efferth T: Cytotoxicity and modes of action of four Cameroonian dietary spices ethno-medically used to treat cancers: Echinops giganteus, Xylopia aethiopica, Imperata cylindrica and Piper capense. J Ethnopharmacol 149, 245–253, 2013.
   PubMed Web of Science ®Google Scholar
• Kuete V, Sandjo LP, Ouete JL, Fouotsa H, Wiench B, et al.: Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines. Phytomedicine 21, 315–322, 2014.
   PubMed Web of Science ®Google Scholar
• Kuete V, Ango PY, Yeboah SO, Mbaveng AT, Mapitse R, et al.: Cytotoxicity of four Aframomum species (A. arundinaceum, A. alboviolaceum, A. kayserianum and A. polyanthum) towards multi-factorial drug resistant cancer cell lines. BMC Complement Altern Med 14, 340, 2014.
   PubMed Web of Science ®Google Scholar
• Kuete V, Sandjo LP, Djeussi DE, Zeino M, Kwamou GM, et al.: Cytotoxic flavonoids and isoflavonoids from Erythrina sigmoidea towards multi-factorial drug resistant cancer cells. Invest New Drugs 32, 1053–1062, 2014.
   PubMed Web of Science ®Google Scholar
• Hamm R, Sugimoto Y, Steinmetz H, and Efferth T: Resistance mechanisms of cancer cells to the novel vacuolar H(+)-ATPase inhibitor archazolid B. Invest New Drugs 32, 893–903, 2014.
   PubMed Web of Science ®Google Scholar
• Afifi FU, Khalil E, Tamimi SO, and Disi A: Evaluation of the gastroprotective effect of Laurus nobilis seeds on ethanol induced gastric ulcer in rats. J Ethnopharmacol 58, 9–14, 1997.
   PubMed Web of Science ®Google Scholar
• Loizzo MR, Tundis R, Menichini F, Saab AM, and Statti GA: Cytotoxic activity of essential oils from labiatae and lauraceae families against in vitro human tumor models. Anticancer Res 27, 3293–3299, 2007.
   PubMed Web of Science ®Google Scholar
• Saab AM, Tundis R, Loizzo MR, Lampronti I, Borgatti M, et al.: Antioxidant and antiproliferative activity of Laurus nobilis L. (Lauraceae) leaves and seeds essential oils against K562 human chronic myelogenous leukaemia cells. Nat Prod Res 26, 1741–1745, 2012.
   PubMed Web of Science ®Google Scholar
• Saab AMLI, Grandini A, Borgatti M, Finotti A, Sacchetti G, et al.: Antiproliferative and erythoid differentiation activities of Cedrus libani seed extracts against K562 human chronic myelogenous leukemia cells. Int J Pharm Biol Arch 2, 1658–1662, 2011.
   Google Scholar
• Rossi DGA, Maietti S, Bruni R, Paganetto G, Poli F, et al.: Chemical fingerprinting and bioactivity of Amazonian Ecuador Croton lechleri Müll. Arg. (Euphorbiaceae) stem bark essential oil: a new functional food ingredient? Food Chemistry 126, 837–848, 2011.
   Web of Science ®Google Scholar
• Kimmig A, Gekeler V, Neumann M, Frese G, Handgretinger R, et al.: Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. Cancer Res 50, 6793–6799, 1990.
   PubMed Web of Science ®Google Scholar
• Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, et al.: Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 64, 382–394, 2003.
   PubMed Web of Science ®Google Scholar
• Gillet JP, Efferth T, Steinbach D, Hamels J, de Longueville F, et al.: Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res 64, 8987–8993, 2004.
   PubMed Web of Science ®Google Scholar
• O'Brien J, Wilson I, Orton T, and Pognan F: Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267, 5421–5426, 2000.
   PubMedGoogle Scholar
• Kuete V, Wiench B, Hegazy ME, Mohamed TA, Fankam AG, et al.: Antibacterial activity and cytotoxicity of selected Egyptian medicinal plants. Planta Med 78, 193–199, 2012.
   PubMed Web of Science ®Google Scholar
• Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, et al.: Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83, 757–766, 1991.
   PubMed Web of Science ®Google Scholar
• Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, et al.: A gene expression database for the molecular pharmacology of cancer. Nat Genet 24, 236–244, 2000.
   PubMed Web of Science ®Google Scholar
• Amundson SA, Do KT, Vinikoor LC, Lee RA, Koch-Paiz CA, et al.: Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res 68, 415–424, 2008.
   PubMed Web of Science ®Google Scholar
• Efferth T, Fabry U, and Osieka R: Apoptosis and resistance to daunorubicin in human leukemic cells. Leukemia 11, 1180–1186, 1997.
   PubMed Web of Science ®Google Scholar
• Ok S: Fast screening of Turkish olive oil by NMR spectroscopy for geographical determination and discrimination purposes. Grasas Aceites 65(2), e024, 2014.
   Web of Science ®Google Scholar
• Sacchi R, Addeo F, and Paolilllo L: 1H and 13C NMR of virgin olive oil. An overview. Magn Reson Chem 35, S133–S145, 1997.
   Web of Science ®Google Scholar
• Marzouki HMH, Khaldi AH, Koujia ML, Piras A, Giordano E, Cet al.: Fatty acid composition, essential oil, and antibacterial activity of berries of Laurus nobilis L. J Essent Oil Bear Pl 12, 422–434, 2009.
   Web of Science ®Google Scholar
• Mahringer A, Karamustafa S, Klotz D, Kahl S, Konkimalla VB, et al.: Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine. Cancer Genomics Proteomics 7, 191–205, 2010.
   PubMedGoogle Scholar
• Efferth T, Konkimalla VB, Wang YF, Sauerbrey A, Meinhardt S, et al.: Prediction of broad spectrum resistance of tumors towards anticancer drugs. Clin Cancer Res 14, 2405–2412, 2008.
   PubMed Web of Science ®Google Scholar
• Goldsborough AS, Handley MD, Dulcey AE, Pluchino KM, Kannan P, et al.: Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin. J Med Chem 54, 4987–4997, 2011.
   PubMed Web of Science ®Google Scholar
• Pluchino KM, Hall MD, Goldsborough AS, Callaghan R, and Gottesman MM: Collateral sensitivity as a strategy against cancer multidrug resistance. Drug Resist Updat 15, 98–105, 2012.
   PubMed Web of Science ®Google Scholar
• Efferth T and Koch E: Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr Drug Targets 12, 122–132, 2011.
   PubMed Web of Science ®Google Scholar
• Efferth T, Miyachi H, Drexler HG, and Gebhart E: Methylthioadenosine phosphorylase as target for chemoselective treatment of T-cell acute lymphoblastic leukemic cells. Blood Cells Mol Dis 28, 47–56, 2002.
   PubMed Web of Science ®Google Scholar
• Efferth T, Verdorfer I, Miyachi H, Sauerbrey A, Drexler HG, et al.: Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines. Blood Cells Mol Dis 29, 1–13, 2002.
   PubMed Web of Science ®Google Scholar
• Villeneuve DJ and Parissenti AM: The use of DNA microarrays to investigate the pharmacogenomics of drug response in living systems. Curr Top Med Chem 4, 1329–1345, 2004.
   PubMed Web of Science ®Google Scholar
• Zeeberg BR, Liu H, Kahn AB, Ehler M, Rajapakse VN, et al.: RedundancyMiner: De-replication of redundant GO categories in microarray and proteomics analysis. BMC Bioinformatics 12, 52, 2011.
   PubMed Web of Science ®Google Scholar
• Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, et al.: CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res 72, 3499–3511, 2012.
   PubMed Web of Science ®Google Scholar
• Efferth T: Personalized cancer medicine: from molecular diagnostics to targeted therapy with natural products. Planta Med 76, 1143–1154, 2010.
   PubMed Web of Science ®Google Scholar
• Efferth T: Stem cells, cancer stem-like cells, and natural products. Planta Med 78, 935–942, 2012.
   PubMed Web of Science ®Google Scholar
• Efferth T: Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules. Curr Med Chem 19, 5735–5744, 2012.
   PubMed Web of Science ®Google Scholar
• Estey E. Acute myeloid leukemia and myelodysplastic syndromes in older patients. J Clin Oncol 25, 1908–1915, 2007.
   PubMed Web of Science ®Google Scholar
• Ko RH, Ji L, Barnette P, Bostrom B, Hutchinson R, et al.: Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study. J Clin Oncol 28, 648–654, 2010.
   PubMed Web of Science ®Google Scholar
• Bassan R and Hoelzer D: Modern therapy of acute lymphoblastic leukemia. J Clin Oncol 29, 532–543, 2011.
   PubMed Web of Science ®Google Scholar
• Ghadimi BM, Grade M, Difilippantonio MJ, Varma S, Simon R, et al:. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23, 1826–1838, 2005.
   PubMed Web of Science ®Google Scholar
• Kim IJ, Lim SB, Kang HC, Chang HJ, Ahn SA, et al.: Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum 50, 1342–1353, 2007.
   PubMed Web of Science ®Google Scholar
• Swanton C, Szallasi Z, Brenton JD, and Downward J: Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer. Breast Cancer Res 10, 214, 2008.
   PubMed Web of Science ®Google Scholar
• Saeed MKH, Sugimoto Y, and Efferth T: The lignan, (-)-sesamin reveals cytotoxicity towards cancer cells: pharmacogenomic determination of genes associated with sensitivity or resistance. Phytomedicine 21, 689–696, 2014.
   PubMed Web of Science ®Google Scholar